Cochrane Review Group
Musculoskeletal
143 systematic reviews in Musculoskeletal ask 1,956 questions. 28.4% have no studies to answer them, 13% rest on very low certainty evidence and 24.8% reach moderate or high certainty.
Reviews
143
Questions
1,956
current versions
No studies
28.4%
Moderate or high
24.8%
No studies 555 · 28.4%Ungraded 107 · 5.5%Very low 255 · 13%Low 555 · 28.4%Moderate 357 · 18.3%High 127 · 6.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Methotrexate vs placebo Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Treatment responsea · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Participant global assessment of well‐being · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Serious adverse events(12 months) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | Very low |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 143
Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle
CochraneSoF table
6 questions
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non‐radiographic axial spondyloarthritis)
CochraneSoF table
14 questions
Selective serotonin reuptake inhibitors for fibromyalgia syndrome
CochraneSoF table
7 questions
Methotrexate for treating rheumatoid arthritis
CochraneSoF table
7 questions
Oral herbal therapies for treating osteoarthritis
CochraneSoF table
56 questions
Oral or transdermal opioids for osteoarthritis of the knee or hip
CochraneSoF table
6 questions
Preoperative education for hip or knee replacement
CochraneSoF table
14 questions
Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis
CochraneSoF table
21 questions
Osteotomy for treating knee osteoarthritis
CochraneSoF table
14 questions
Continuous passive motion following total knee arthroplasty in people with arthritis
CochraneSoF table
7 questions
Sulfasalazine for ankylosing spondylitis
CochraneSoF table
7 questions
Diacerein for osteoarthritis
CochraneSoF table
7 questions
Chinese herbal medicines for treating osteoporosis
CochraneSoF table
28 questions
Allopurinol for chronic gout
CochraneSoF table
21 questions
Exercise for osteoarthritis of the hip
CochraneSoF table
8 questions
Self‐management education programmes for osteoarthritis
CochraneSoF table
28 questions
Interleukin‐1 inhibitors for acute gout
CochraneSoF table
14 questions
Uricosuric medications for chronic gout
CochraneSoF table
21 questions
Manual therapy and exercise for adhesive capsulitis (frozen shoulder)
CochraneSoF table
42 questions
Electrotherapy modalities for adhesive capsulitis (frozen shoulder)
CochraneSoF table
21 questions
Aquatic exercise training for fibromyalgia
CochraneSoF table
14 questions
Erythropoiesis‐stimulating agents for anemia in rheumatoid arthritis
CochraneSoF table
7 questions
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
CochraneSoF table
21 questions
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
CochraneSoF table
7 questions
Electromagnetic fields for treating osteoarthritis
CochraneSoF table
6 questions